Clinical trial
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem…
NCT00388349 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00388349 |
|---|---|
| Title | Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease |
| Official title | Gemcitabine and High-dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin Disease, Hodgkin's Lymphoma, Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Gemcitabine, Vinorelbine, Carmustine, Etoposide, Cyclophosphamide, Autologous HCT |
| Enrollment | 146 |
| Start date | Sep 1, 2001 |
| Primary completion | Mar 1, 2008 |
| Completion | Sep 1, 2010 |
| First posted | Oct 16, 2006 |
| Last update posted | Jun 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: